Ra Capital Management, L.P. Imara Inc. Transaction History

Ra Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.73 - $5.2 $12.1 Million - $16.9 Million	3,250,724 New	3,250,724 $13.3 Million
Q3 2021 Nov 15, 2021	SELL	$4.08 - $7.83 $1.02 Million - $1.95 Million	-248,804 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$15.81 - $29.0 $14,782 - $27,115	-935 Reduced 0.37%	248,804 $5.49 Million
Q3 2020 Nov 16, 2020	SELL	$18.75 - $28.58 $10.9 Million - $16.6 Million	-579,609 Reduced 69.89%	249,739 $5.08 Million
Q2 2020 Aug 14, 2020	SELL	$15.6 - $54.87 $9.75 Million - $34.3 Million	-625,000 Reduced 42.97%	829,348 $22.9 Million
Q1 2020 May 15, 2020	BUY	$15.0 - $16.6 $21.8 Million - $24.1 Million	1,454,348 New	1,454,348 $23.3 Million

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.